Date of event: unknown.Device expiration date: unknown; device manufacture date: unknown.(b)(4).Investigation summary: since no samples displaying the condition reported are available for examination, we were unable to fully investigate this incident.No root cause can be determined as no samples were received.The lot number is unknown, therefore, device history record review (dhr) or quality notification review (qn) could not be performed.Complaints received for this device, and reported condition will continue to be tracked, and trended.Information will be captured on trend reports, and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Root cause description: since no samples displaying the reported condition were received a potential root cause could not be defined.
|
It was reported that an unspecified number of bd 1ml tb syringe slip tips were involved with the patient experiencing hyperglycemia after device use.There has been no mention of medical intervention applied as a result of the hyperglycemia.The following infodate received for intake: 25-sep-2020; material no.309623; batch no.0135774.Complaint 3 of 3: spouse of consumer reported they received a supply of completely new syringes and consumer's blood sugars have been elevated.Stated one day consumer's blood sugar was 300 and one day it was 280.Stated on (b)(6) 2020, that it was 182, then 383.Stated on (b)(6) 2020, that it was 255.Stated no one showed them how to use the new syringes, and they are not using them anymore.Stated they still have some of the previous syringes, and they are going to use them because consumer's blood sugars are fine with those syringes.Spouse is going to call insurance company to inform that they received different syringes and inquire about obtaining the previous syringes.
|